(TheNewswire)
Calgary, Alberta – TheNewswire- November 16, 2022 – nDatalyze Corp.(“ NDAT ” or the “ Corporation ”) (CSE:NDAT) (OTC:NDATF) is pleased to announce that the Corporation'smarketing contractor, BelieveCo (formerly VenturePlay), has providedan interim update of the YMI marketing campaign (the"Campaign") progress. BelieveCo reports that after only onemonth, "The media campaign has been performing incredibly"and "the data shows that we're performing well overbenchmarks".
NDAT's President Jim Durward states: " We plannedour work and we're working our plan. I'm very pleased that Phase 1 ofthe marketing strategy has performed so well. As expected, prospectivecustomers were driven to the YMI website and their "in-site"behaviour tracked to provide valuable knowledge into pre-purchasebehaviors during the purchase process. We will now incorporate thisknowledge in Phase 2 and increase the resolution of our behavioraldata gathering to optimize the overall purchase process."
In the near term the Corporation expects to expand theCampaign by:
a) contracting social media influencers - relevantinfluencers have been identified and outreach has begun;
b) incorporating social media "boosts" -expected to begin before November 30, 2022;
c) increasing the digital advertising spend - expectedbefore the end of November, 2022; and
d) expanding the target geography to include all ofCanada - expected before December 15, 2022.
The Corporation further reports that an introductoryprice reduction occurred during Phase 1 and that the small number ofsales that occurred prior to the price reduction were refunded as ashow of goodwill to those customers - meaning the pre-reductioncustomers were effectively given free access to YMI. The refunds willnot have a material effect on the Corporation's financial statements.The Campaign is fully funded by the Corporation's existing cashbalance.
YMI is available now at https://ymihealth.ca /
About nDatalyze Corp.:
nDatalyze Corp. generates technology-based,health-related solutions. The YMI division has developed amachine-learning based, online consumer mental health applicationbased on the Corporation's proprietary Reference Database consistingof >1200 biometric records complete with associated electroencephalogram ("EEG") data. With installations worldwide, it's Medxtractordivision manufactures small-scale bio-extractors that are used toextract compounds from a variety of botanical biomasses. While theMedxtractor division is currently generating cash flow, YMI has only recently launched and accordingly theCorporation cannot accurately predict if or when this application willbecome a cash flow generator.
FOR FURTHER INFORMATION, PLEASECONTACT:
nDatalyze Corp.
James Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@ndatalyze.com Website: www.ndatalyze.com
Investor Relations
RBMG - RB Milestone Group LLC
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available.
The information in this news release includes certaininformation and statements about management's view of future events,expectations, plans and prospects that constitute forward lookingstatements. These statements are based upon assumptions that aresubject to significant risks and uncertainties. Because of these risksand uncertainties and as a result of a variety of factors, the actualresults, expectations, achievements or performance may differmaterially from those anticipated and indicated by these forwardlooking statements. Any number of factors could cause actual resultsto differ materially from these forward-looking statements as well asfuture results. Although the Corporation believes that theexpectations reflected in forward looking statements are reasonable,it can give no assurances that the expectations of any forward-lookingstatements will prove to be correct. Except as required by law, theCorporation disclaims any intention and assumes no obligation toupdate or revise any forward looking statements to reflect actualresults, whether as a result of new information, future events, changes in assumptions, changes in factorsaffecting such forward looking statements or otherwise.
Copyright (c) 2022 TheNewswire - All rights reserved.